Percutaneous posterior tibial nerve stimulation (PTNS) for lower urinary tract symptoms (LUTSs) treatment in patients with multiple sclerosis (MS): a systematic review and meta-analysis.

Author(s):  
Fatemeh Guitynavard ◽  
Omid Mirmosayyeb ◽  
Seyede Zahra Emami Razavi ◽  
Maryam Hosseini ◽  
Ali Mahdi Hosseinabadi ◽  
...  
2001 ◽  
Vol 166 (3) ◽  
pp. 914-918 ◽  
Author(s):  
MICHAEL R. van BALKEN ◽  
VERA VANDONINCK ◽  
KAREL W.H. GISOLF ◽  
HENK VERGUNST ◽  
LAMBERTUS A.L.M. KIEMENEY ◽  
...  

2013 ◽  
Vol 7 (9-10) ◽  
pp. 174 ◽  
Author(s):  
Cornelius Kelleher

For patients with overactive bladder and a suboptimal response to antimuscarinic therapy, there are several options to consider including alteration of the antimuscarinic regimen, switching to an agent with an alternate mechanism of action (i.e., mirabegron), posterior tibial nerve stimulation, or botulinum toxin. These options are summarized in this brief review.


Sign in / Sign up

Export Citation Format

Share Document